What are the indications for rescue percutaneous coronary intervention (PCI) in a patient with ST‑segment elevation myocardial infarction (STEMI) who has not achieved adequate reperfusion after fibrinolytic therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Indications for Rescue PCI After Failed Fibrinolysis in STEMI

Rescue PCI should be performed immediately when ST-segment resolution is less than 50% at 60-90 minutes after fibrinolytic therapy initiation, as this indicates failed reperfusion and is associated with significantly improved survival and reduced cardiovascular events compared to conservative management or repeat fibrinolysis. 1, 2

Primary Indication: Failed Fibrinolysis

Assessment at 60-90 minutes post-fibrinolysis is critical. Evaluate the 12-lead ECG in the lead showing the greatest initial ST-segment elevation. If ST-segment resolution is <50%, fibrinolytic therapy has failed and rescue PCI is indicated. 1, 3, 4

Why This Matters for Outcomes:

  • Rescue PCI reduces death or reinfarction from 16.8% to 10.8% (RR 0.64, p=0.009) compared to conservative management 1
  • Mortality decreases from 10.7% to 6.9% (RR 0.65, p=0.04) with rescue PCI 1
  • Long-term (4-year) mortality is significantly reduced (adjusted HR 0.60) 5
  • Event-free survival at 6 months is 84.6% with rescue PCI versus 70.1% with conservative therapy (p=0.004) 2

Additional High-Risk Indications

Beyond failed ST-segment resolution, rescue PCI is indicated for:

Hemodynamic Instability

  • Cardiogenic shock (Class I for age <75 years; Class IIa for age ≥75 years) 1
  • Persistent hypotension or signs of shock 1, 3

Electrical Instability

  • Sustained ventricular arrhythmias 3
  • Life-threatening arrhythmias despite medical management 1

Ongoing Ischemia

  • Persistent or worsening chest pain despite fibrinolysis 1, 3
  • Recurrent ST-segment elevation after initial improvement 3, 4
  • Evidence of re-occlusion after initial successful reperfusion 3, 4

Heart Failure

  • Development of acute heart failure or pulmonary edema 1

Clinical Assessment Algorithm

At 60-90 minutes post-fibrinolysis, perform this systematic evaluation:

  1. Measure ST-segment resolution in the lead with greatest initial elevation 1, 4

    • ≥50% resolution = successful reperfusion → transfer for routine angiography within 2-24 hours 3, 4
    • <50% resolution = failed reperfusion → immediate rescue PCI 1, 3
  2. Assess clinical markers (though less reliable than ECG):

    • Complete chest pain relief + complete ST resolution + reperfusion arrhythmias = likely success 1
    • However, this triad occurs infrequently and should not be relied upon alone 1
  3. Evaluate hemodynamics and rhythm continuously 1, 3

Critical Timing Considerations

The earlier rescue PCI is performed, the greater the benefit. 1, 4

  • Myocardial salvage is unlikely if coronary occlusion persists >3-6 hours from symptom onset 1
  • Despite time delays inherent in the fibrinolysis-then-rescue pathway, rescue PCI still provides significant mortality benefit 1, 5
  • Patients in whom fibrinolysis fails have worse left ventricular function, increased mechanical complications, and greater mortality without intervention 1

Important Caveats and Pitfalls

Do NOT Rely Solely on Clinical Symptoms

Clinical markers (chest pain relief, reperfusion arrhythmias) have limited predictive value for identifying failed fibrinolysis. 1 Always obtain the 60-90 minute ECG for objective ST-segment assessment. 1

Transfer All Patients Immediately

Every patient receiving fibrinolysis should be transferred to a PCI-capable center immediately after treatment, not just those with obvious failure. 1, 3 This enables:

  • Timely rescue PCI if needed (30.3% of patients require it) 1
  • Routine angiography within 2-24 hours for successful cases 3, 4

Rescue PCI vs. Repeat Fibrinolysis

Never give repeat fibrinolysis as an alternative to rescue PCI. Repeat fibrinolysis shows no mortality benefit (RR 0.68, p=0.14) and increases bleeding risk without reducing reinfarction rates. 6, 2 The REACT trial demonstrated rescue PCI is superior to both repeat fibrinolysis and conservative management. 2

Underutilization in Practice

Despite strong evidence, rescue PCI is substantially underused—only 34.7% of eligible patients receive it in real-world practice. 5 The strongest predictor of receiving rescue PCI is initial presentation to a PCI-capable hospital, highlighting the importance of immediate transfer protocols. 5

Procedural Risks

Rescue PCI carries increased risks compared to primary PCI:

  • Increased stroke risk (RR 4.98) 6
  • Minor bleeding complications, mostly at vascular access sites 6, 2
  • 10% failure rate to restore flow 1
  • Up to 20% reocclusion rate (though modern stents and GP IIb/IIIa inhibitors have improved this) 1

However, these risks are outweighed by the mortality benefit in patients with failed fibrinolysis. 1, 5, 2

Contemporary Evidence Strength

The recommendation for rescue PCI is based on multiple randomized trials (REACT, MERLIN, RESCUE) and meta-analyses encompassing over 1,100 patients, with consistent benefit demonstrated across studies. 1, 6, 2 Modern trials using stents and GP IIb/IIIa inhibitors show even better outcomes than earlier balloon-only studies. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Streptokinase Use in STEMI When Primary PCI Is Not Feasible

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

ST Elevation Resolution Timeframe After Reperfusion Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Do you use nitroglycerin (nitro) for right-sided ST-elevation myocardial infarction (STEMI)?
What are the expected accelerated benefits for a 58-year-old patient with a history of myocardial infarction (MI) with ST-elevation myocardial infarction (STEMI) and stent placement, but no heart damage, who has a calculated life expectancy of 26 years and holds a 90% accelerated short-term life insurance policy for $500,000?
In a 58-year-old man presenting with crushing chest pain radiating to the left arm and anterior ST‑elevation myocardial infarction (STEMI) on ECG (leads V2‑V4) with no prior medical history, what is the most appropriate definitive treatment?
What are the absolute and relative contraindications for thrombolysis in a patient with ST-Elevation Myocardial Infarction (STEMI)?
What is the immediate next step in managing a 38‑year‑old woman with a 10‑day history of exertional dyspnea, left‑sided chest pain radiating to the back, intermittent four‑limb numbness, bilateral pitting leg edema, treadmill test (TMT) showing ST‑segment depression in leads II, III, aVF and reciprocal ST‑segment elevation in leads I, aVL, V2‑V6 consistent with an acute anterior ST‑segment elevation myocardial infarction (STEMI), normal echocardiogram (Echo), and cervical spine magnetic resonance imaging (MRI) revealing mild C4‑5 and C5‑6 disc bulges?
How should I taper hydrocodone 10 mg/acetaminophen 325 mg in a patient with fracture pain who is experiencing opioid‑induced urinary retention and is currently taking mirabegron?
What are the indications for percutaneous coronary intervention (PCI) in adults with coronary artery disease?
What is the appropriate antenatal follow‑up plan for a pregnant woman with known rheumatic heart disease to keep her cardiac status stable, prevent rheumatic fever recurrences, and ensure a safe delivery?
Will increasing escitalopram from 5 mg to about 7.5 mg relieve persistent generalized anxiety, hypervigilance, and derealization in an adult after an abrupt dose reduction?
Can Ontario Health Authority (OHA) care coordinators initiate hospice referrals for patients?
What is the most appropriate initial therapy for uncomplicated toe‑nail onychomycosis in an adult?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.